Europe comes to Canada as Lochmüller Lab hosts the annual meeting of the ProDGNE consortium

This August we welcomed our international colleagues of the ProDGNE consortium to Ottawa as we hosted the annual meeting of ProDGNE, the three-year transnational pre-clinical research project.  

Welcoming colleagues from around the world

From the from the 4th to the 5th of August we had the pleasure of hosting project investigators Drs. Fabrizio Pertusati (Lecturer, Cardiff University, UK), Paula Videira (Assistant Professor, Universidade NOVA de Lisboa, Portugal), Pierluigi Caboni (Professor, University of Cagliari, Italy) and Rüdiger Horstkorte (Professor, Martin-Luther University Halle-Wittenberg, Germany), patient representative Michela Onali (Gli Equilibristi HIBM, Italy), and several students and postdocs involved with ProDGNE. The group met over two days on the University of Ottawa campus to discuss the project deliverables, and share updates in the field of research and therapy development for GNE myopathy. 

Members of the ProdGNE consortium gathered around table.

Members of the ProdGNE consortium gathered in Ottawa for a working meeting.

Full agenda for both days of the meeting

Renowned researchers Drs Stella Mitrani-Rosenbaum (Hebrew University of Jerusalem) and David Wishart (University of Alberta, Edmonton) presented keynote talks to begin each day of the conference. Dr Mitrani-Rosenbaum presented past and current challenges of modeling GNE myopathy in zebrafish and mice, and Dr Wishart spoke on targeted metabolomics as a method to uncover biomarkers of rare diseases, covering his recent findings in GNE myopathy patient samples. After project updates from all work package leaders, collaborator Dr Andreas Roos delivered a presentation on biomarker research and proteins. Flash presentations were given by young investigators Mariana Barbosa (FCT NOVA), James Morewood (Cardiff University), Rebecca Rosenstengel, Elfrun Meyer and Linus Weilepp (MLU), and Alexa Derksen, Jarred Lau and Stephen Holland (Lochmüller Lab).

Exploring Ottawa

Following each day’s productive sessions, we had the chance to showcase Ottawa as Canada’s capital city. The group toured the parliament buildings and historic Byward Market and explored the Gatineau Park’s rolling hills and Pink Lake.

Michela Onali and Hanns Lochmüller on a path.

Michela Onali and Hanns Lochmüller explore the beautiful Gatineau park.

Looking ahead to the next project meeting

This meeting marks the end of ProDGNE’s second year. The consortium will reconvene for its final meeting in in April 2024 in Cagliari, Sardinia, Italy.  

Project funders

ProDGNE is funded under the European Joint Programme on Rare Diseases (EJP RD) Joint Transnational Call 2020 “Pre-Clinical Research to Develop Effective Therapies for Rare Diseases”. The project receives funding from the European Commission (EC) under the Horizon 2020 EJP-COFUND action and from national funding organisations. The Canadian contribution is funded by the Canadian Institutes of Health Research – Institute of Genetics. 

 

The ProdGNE consortium posing in front of building.

Read next...

First participant screened in global CMS natural history study

The Ottawa Neuromuscular Centre screens first participant in the world for a multinational congenital myasthenic syndrome natural history study

The neuromuscular centre at The Ottawa Hospital is excited to announce that we are the first site globally to screen a participant for the multinational...
Copy of Lochmuller Lab - PhD opportunity (LLab)

Lochmüller Lab seeking PhD student

The Lochmüller Research Group are seeking a highly motivated PhD student to join our team at the Childrens Hospital of Eastern Ontario Research Institute (CHEO...
New Publication - Leading global expert in DMD and bone health Dr. Leanne Ward publishes systematic review and grading of evidence for biphosphonate therapy in glucocorticoid-treated patients with Duchenne Muscular Dystrophy in Neurology, with Dr. Hanns Lochmüller as a co-author.

New Publication: Bisphosphonates in Glucocorticoid-Treated Patients with Duchenne Muscular Dystrophy: A Systematic Review and Grading of the Evidence

Leading global expert in Duchenne Muscular Dystrophy (DMD) and bone health Dr. Leanne Ward publishes systematic review and grading of evidence for bisphosphonate therapy in...
text reding new clinical trial opportunities

New Clinical Trial Opportunities for Children and Adults in Ottawa

Our clinical research team is excited to share five new clinical trials activated across both pediatric and adult sites in Ottawa, CHEO and TOH. We...
Dr. Andreas Roos receiving award on WMS 2023 stage, with text reading Congratulaions Dr. Andreas Roos, WMS President's Prize for Emerging Myologist of the Year 2023.

Dr. Andreas Roos wins Emerging Myologist of the Year Prize at WMS 2023

We are excited to congratulate Dr. Andreas Roos on winning the World Muscle Society’s (WMS) President’s Prize for Emerging Myologist of the Year!   This award...
Lochmüller Lab members gather for a group photo at the Ottawa NMD poster session.

Lochmüller Lab at Ottawa NMD 2023

This September 7th to 9th the University of Ottawa Éric Poulin Centre for Neuromuscular Disease (CNMD) hosted the 6th Ottawa International Conference on Neuromuscular Disease...